According to preliminary results published in The Lancet journal, the COVID-19 vaccine, Sputnik V, approved by Russia last month has been shown to elicit antibody resonse with no serious adverse events in small human trials.

Russian vaccine is safe, shows no side effects: Lancet Report

India on Tuesday expressed interest in getting Russian COVID vaccine Sputnik V according to a statement. The statement on the website dedicated to the "world's first registered Covid-19 vaccine" lists out India along with 20 other countries that have shown interest in getting the vaccine.

The statement says," At least 20 countries had expressed interest in obtaining the Sputnik V, including UAE, Saudi Arabia, Indonesia, Philippines, Brazil, Mexico and India."

Russian President Vladimir Putin on Tuesday announced his country has come out with vaccine against COVID, with one dose being given to his daughters.&nbsp;

Russian Direct Investment Fund or RDIF, Russia's Sovereign wealth fund is financing the production of the vaccine and sees "strong global interest in the vaccine", according to the statement.&nbsp;

The statement explained RDIF plans to "conduct Phase 3 clinical trials in different countries, including Saudi Arabia, UAE, Brazil, India and Philippines" and "start mass production in other countries in partnership with local sovereign wealth funds, including India, South Korea and Brazil, as well as, in Saudi Arabia, Turkey and Cuba."

Mass production of the vaccine is expected to start in September 2020. Future plans include ramping up the vaccine production to 200 million doses by the end of 2020 including 30 million doses in Russia.

India on Tuesday expressed interest in getting Russian COVID vaccine Sputnik V according to a statement. The statement on the website dedicated to the "world's first registered Covid-19 vaccine" lists out India along with 20 other countries that have shown interest in getting the vaccine.

India on Tuesday expressed interest in getting Russian COVID vaccine Sputnik V according to a statement. The statement on the website dedicated to the "world's first registered Covid-19 vaccine" lists out India along with 20 other countries that have shown interest in getting the vaccine. The statement says," At least 20 countries had expressed interest in obtaining the Sputnik V, including UAE, Saudi Arabia, Indonesia, Philippines, Brazil, Mexico and India." Russian President Vladimir Putin on Tuesday announced his country has come out with vaccine against COVID, with one dose being given to his daughters. Russian Direct Investment Fund or RDIF, Russia's Sovereign wealth fund is financing the production of the vaccine and sees "strong global interest in the vaccine", according to the statement. The statement explained RDIF plans to "conduct Phase 3 clinical trials in different countries, including Saudi Arabia, UAE, Brazil, India and Philippines" and "start mass production in other countries in partnership with local sovereign wealth funds, including India, South Korea and Brazil, as well as, in Saudi Arabia, Turkey and Cuba." Mass production of the vaccine is expected to start in September 2020. Future plans include ramping up the vaccine production to 200 million doses by the end of 2020 including 30 million doses in Russia.

Russian COVID-19 vaccine: New Delhi expresses interest as Moscow scouts for mass production in India

russian-covid-19-vaccine

Russian Covid 19 Vaccine, News on Russian Covid 19 Vaccine, stories on Russian Covid 19 Vaccine, articles on Russian Covid 19 Vaccine, Russian Covid 19 Vaccine stories at Wion, Russian Covid 19 Vaccine news, Russian Covid 19 Vaccine latest news

russian covid-19-vaccine

Russian vaccine is safe, shows no side effects: Lancet Report

Russian COVID-19 vaccine: New Delhi expresses interest as Moscow scouts for mass production in India